Original Research
Published on 04 Apr 2025
Pembrolizumab versus bevacizumab plus modified FOLFOX6 in metastatic MSI-H/dMMR colorectal cancer: a multicenter retrospective study with CT evaluation
in Gastrointestinal Cancers: Colorectal Cancer
- 118 views